Here is What Hedge Funds Think About Foamix Pharmaceuticals Ltd (FOMX)
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
Foamix Pharmaceuticals Ltd. (FOMX)
This company is not actively trading or the ticker does belong to another company in our database now.
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Highland Capital Management James Dondero | 0 | $0 | 0% | |
| 2. | ARK Investment Management Catherine D. Wood | 0 | $0 | 0% | |
| 3. | Perceptive Advisors Joseph Edelman | 0 | $0 | 0% | |
| 4. | OrbiMed Advisors Samuel Isaly | 0 | $0 | 0% | |
| 5. | 683 Capital Partners Ari Zweiman | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.76 | 13,440 | $50,534.40 | 63,440 | 2019-03-05 | Filing | |
| $3.88 | 12,200 | $47,372.60 | 112,200 | 2018-11-28 | Filing | |
| $3.92 | 50,000 | $195,800.00 | 100,000 | 2018-11-27 | Filing | |
| $3.89 | 50,000 | $194,600.00 | 50,000 | 2018-11-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.50 | 34,392 | $120,375.44 | 89,279 | 2019-09-10 | Filing | |
| $3.50 | 9,420 | $32,990.72 | 123,671 | 2019-09-09 | Filing | |
| $3.27 | 7,049 | $23,050.23 | 37,498 | 2019-08-26 | Filing | |
| $2.31 | 808 | $1,866.48 | 44,547 | 2019-07-15 | Filing | |
| $2.35 | 639 | $1,501.65 | 51,969 | 2019-07-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is Foamix Pharmaceuticals Ltd (FOMX) A Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their...
Is Foamix Pharmaceuticals Ltd (FOMX) A Good Stock To Buy?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies ...
Perceptive Advisors and Foamix Pharmaceuticals Ltd.
Joe Edelman's Perceptive Advisors tripled its Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) position following company's offering.
15 Penny Stocks Poised To Explode According To Hedge Funds
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share. There are thousands or...
13G Filing: Great Point Partners and Foamix Pharmaceuticals Ltd (FOMX)
The Reporting Persons have entered into a Joint Filing Agreement, dated May 10, 2017, a copy of which is filed with this Schedule 13G/A as Exhibit A, pursuant to which the Reporting Persons have agreed...
What is Going on With Foamix Pharmaceuticals Ltd (FOMX)?
Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) shares have fallen 43% this morning after the company released disappointing top-line results from its phase 3 trials for FMX101 for patients with moderate-to...
Is Foamix Pharmaceuticals Ltd (FOMX) Going to Burn These Hedge Funds?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Foamix Pharmaceuticals Ltd. (FOMX) Stock: Great Point Partners Boosts its Stake to 7.57%
Jeffrey Jay and David Kroin's Great Point Partners recently filed a Form 13G with the Securities and Exchange Commission in which it reported a significant increase to its stake in Foamix Pharmaceuticals...
Here Is Why Investors Are Pushing Foamix Pharmaceuticals Ltd (FOMX) Higher Today
Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) is trending higher today after the company announced top-line results for one of its drug candidates.
Hedge Fund Resource Center